MINNEAPOLIS, July 26, 2017 -- Minnesota’s Own KARE 11, the NBC affiliate in Minneapolis-St. Paul, MN has been nominated for the National News & Documentary Emmy, in the regional investigative category. The honor was announced Tuesday by The National Academy of Television Arts & Sciences.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/274b60da-24b6-4289-a8e0-85a5972af8b8
KARE 11’s investigation, led by Steve Eckert, A.J. Lagoe and Gary Knox, revealed the Department of Veterans Affairs used unqualified medical personnel for examinations and denied benefits for traumatic brain injuries (TBI) at the Minneapolis VA Medical center. Following this report, a federal investigation was opened on similar issues at other VA facilities across the country and found nearly 25,000 veterans nationwide received improper examinations for TBI.
In the wake of KARE 11’s investigation, Congress held a hearing on the issue and the VA announced it was offering the veterans reexamination by qualified doctors. In Minnesota, half of the veterans originally denied TBI benefits were determined, after reexamination, to have suffered traumatic brain injuries.
“We are humbled and proud that KARE 11 Investigates has been recognized as a National Regional Emmy finalist,” said News Director Jane Helmke. “Though the real honor is the positive impact and action our team’s work has had on the lives of veterans in Minnesota and across the nation.”
KARE 11’s ongoing Investigative series on behalf of veterans has already garnered other prestigious National recognition including the George Polk Award and the IRE (Investigative Reporters and Editors) Award.
For link to the story: <http://www.kare11.com/news/investigations/invisible-wounds-a-report-on-the-va-and-vets-with-traumatic-brain-injuries/215102774>.
KARE 11 is the Minneapolis/St. Paul, TEGNA-owned, NBC affiliate.
About TEGNA
TEGNA Inc. (NYSE:TGNA) is comprised of a dynamic portfolio of media and digital businesses that provide content that matters and brands that deliver. TEGNA offers highly relevant, useful and smart content, when and how people need it, to make the best decisions possible. TEGNA Media includes 46 television stations and is the largest independent station group of major network affiliates in the top 25 markets, reaching approximately one-third of all television households nationwide. TEGNA Digital is comprised of Cars.com, the leading online destination for automotive consumers, CareerBuilder, a global leader in human capital solutions, and G/O Digital, a customized local digital marketing company. For more information, visit www.TEGNA.com.
For media inquiries, contact: Janeen Vogelaar 763-797-7270 [email protected]


Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 



